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Objective: To assess the clinical relevance of mean and minimum femorotibial joint space narrowing (JSN)
for predicting future osteoarthritis related surgery in patients with knee osteoarthritis.
Methods: 126 subjects with primary knee osteoarthritis were followed prospectively for a mean eight
years. Minimum and mean joint space width (JSW) were assessed from standard x rays at baseline and
after a follow up of three years. The rate of knee osteoarthritis related surgery was recorded for the
following five years.
Results: After a mean follow up of eight years, 16 patients (12.7%) had received osteoarthritis related joint
surgery. The areas under the curves (AUC) resulting from the receiver operating characteristic curve
analyses for predicting osteoarthritis surgery were 0.73 (p = 0.006) for minimum JSN and 0.55 (p = 0.54)
for mean JSN. The cut off for minimum JSN maximising sensitivity and specificity for predicting future
surgery was a change of 0.7 mm or more in minimum joint space width over a period of three years.
However, no meaningful differences were observed for cut off values between 0.5 and 0.8 mm The
relative risk (adjusted for age, body mass index, baseline symptoms, and baseline JSW) of experiencing
osteoarthritis related surgery during the eight year of follow up was 5.15 (95% confidence interval, 1.70 to
15.60) (p = 0.004) in patients with a minimum joint space narrowing of 0.7 mm or more during the first
three years of the study.
Conclusions: A cut off of 0.5 to 0.8 mm in minimum JSN, measured on standard x rays, reflects a clinically
relevant progression in patients with knee osteoarthritis.
D
uring the last few years, major advances have been
made in the treatment of osteoarthritis.1 The current
management includes non-pharmacological and non-
surgical measures, the use of pharmacological agents, and
surgery.2 3 According to recommendations from expert panels
and regulatory authorities, drugs used for the treatment of
osteoarthritis can be classified as symptom modifying or
structure modifying agents, depending on their ability to
control the symptoms of the disease or the progression of
joint structural changes.2–5 Structural modification of the
joint is considered to be the most important determinant of
disease progression. Structure modifying agents have thus
been assimilated into disease modifying agents. Change in
joint space width, measured on standard x rays, is currently
the recommended primary end point in trials assessing new
chemical agents for treating osteoarthritis, for both scientific
organisations5 6 and regulatory agencies in the USA and
Europe.2 3
However, to date, very few prospective long term studies
have confirmed the surrogacy of joint space narrowing for
relevant hard clinical end points—that is, the long term
incidence of osteoarthritis related joint surgery.
Subsequently, the exact clinical relevance of the results
obtained in studies showing the ability of an anti-osteoar-
thritis drugs to delay, reduce, or prevent joint space
narrowing remains equivocal. Knee surgery is widely
recognised as the single most relevant outcome in knee
osteoarthritis. The need for such a procedure usually reflects
the failure of non-surgical treatment and it is only under-
taken in patients with painful and debilitating disease.7 8
Our aim in the present study was to confirm prospectively
the long term clinical relevance of joint space narrowing—
that is, the ability of this radiological feature to predict the
risk of future knee surgery.
METHODS
Patients
The study population comprised 139 subjects, of both sexes,
aged from at least 50 years, with primary knee osteoarthritis
diagnosed according to the clinical and radiological criteria of
the American College of Rheumatology.9 They correspond to
the patients who completed a previously described three year
prospective double blind, placebo controlled study.10 These
subjects were contacted for a follow up survey, up to eight
years (mean duration 5.0 years) after the end of the three
year intervention period. At that time, the incidence of knee
surgery, including total knee arthroplasty and knee joint
debridement/meniscectomy, was recorded.
Acquisit ion of x rays
Standard radiographs were taken for each knee at baseline
and after three years. The signal joint was used for
radiographic assessment. Radiographs were obtained accord-
ing to the gold standard technique available at the time of
study design—that is, in the standing (weight bearing)
anteroposterior fully extended knee view. The posterior
aspect of the knee was in contact with the x ray cassette in
order to avoid variation in the distance between the knee and
Abbreviations: AUC, area under the curve; JSN, joint space narrowing
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the cassette through the study. Fluoroscopy was used to
direct the x ray beam to the centre of the joint space, to
control for joint rotation and thus maintain the same degree
of alignment with the tibial plateau in subsequent radio-
graphs. Patient repositioning was guided by the baseline film
and aided by foot maps.
Mean joint space width assessment
Radiographs were digitised and image analysis was carried
out according to a validated technique11 which located the
proximal and distal joint margins, excluding outlier points,
and calculated the mean joint space width (JSW) of the
medial compartment of the tibiofemoral joint. The mean
(SD) short term and long term coefficient of variation of this
system for reproducing measurements was 1.82 (1.29)% and
1.62 (1.31)%, respectively.10
Minimum joint space width assessment
The minimum joint space width—that is, the narrowest point
of the medial compartment of the femorotibial joint—was
assessed by visual determination using a 0.1 mm graduated
magnifying lens, as described previously.12
Statistical analysis
The areas under receiver operating characteristic (ROC)
curves measuring the respective value of mean and minimal
JSN for the prediction of the incidence of knee surgery were
calculated. For various cut off points of mean or minimum
JSN, the relative risk of undergoing knee surgery, and the
specificity, sensitivity, and positive and negative predictive
values were also determined. At the least, we assessed the
overall efficiency of various cut off points of JSN for the
prediction of knee surgery over the subsequent five years.
RESULTS
Of 139 patients who completed the three year initial trial, 13
(9.3%) could not be reached at the time of the follow up
evaluation. Their baseline demographic characteristics did
not differ from those of the overall cohort (table 1). This left a
total of 126 patients (90.7%) assessable in the present study.
During a median follow up of 5.0 years (mean 3.8, maximum
8.0) after the end of the original study, 16 patients (12.7%)
had received knee surgery. These surgical procedures
included 11 total knee replacements (68.8%) and five joint
debridement/meniscectomies (31.2%). While some patients
had surgery in both knees, this intervention occurred more
often (in over 60%) in the target knee in the initial study.
The areas under ROC curves measuring the respective
value of mean and minimum JSN for the prediction of the
incidence of knee surgery are reported in fig 1. Minimum
(p=0.006), but not mean (p=0.51), JSN after three years
was highly predictive of the risk of requiring osteoarthritis
related knee surgery within a further period of five years.
The relative risk of undergoing knee surgery, and the
specificity, sensitivity, and positive and negative predictive
values for various cut off points of mean or minimum JSN,
are presented in tables 2 and 3. While a cut off value of
0.7 mm for minimum JSN after three years provides the best
numerical overall efficiency for predicting the incidence of
future knee surgery, no meaningful differences were
observed for cut off values between 0.5 and 0.8 mm (relative
risks for future surgery all above 4.5, and all overall
efficiencies above 70%).
DISCUSSION
Whereas clinical outcomes for the assessment of symptomatic
improvement in osteoarthritis of the lower limb (that is, the
Western Ontario and McMaster Universities index, the
Lequesne algo-functional index, and so on) are well estab-
lished, there is still debate over the most appropriate way of
assessing a drug aimed at reducing, delaying, or preventing the
structural progression of osteoarthritis. There is a large
consensus that the incidence of lower limb surgery is the most
relevant clinical outcome, but on practical grounds the
assessment of this particular end point would request studies
involving massive cohorts of patients over several years.6
Furthermore, the decision process for osteoarthritis related
surgery may be affected by various non-medical conditions,
including sex, race, and socioeconomic status.13 In fact, there
are no widely accepted guidelines defining the exact profile of a
patient undergoing osteoarthritis related surgery.14 All these
elements make the design of a clinical trial to assess a potential
structure modifying agent in osteoarthritis on the basis of the




3 y study (n = 139)
Patients lost during
the 5 y follow up
(n = 13)
Patients included in
the 5 y follow up
analysis (n = 126)
Women 97 (70%) 9 (69%) 88 (70%)
Age (years) 64.5 (6.9) 69.4 (8.0) 64.7 (7.0)
Body mass index (kg/m2) 27.3 (2.8) 26.5 (2.5) 27.3 (2.8)
Mean joint space width (mm) 5.4 (1.3) 5.4 (1.3) 5.4 (1.3)
Minimum joint space width (mm) 3.9 (1.2) 3.9 (1.3) 4.0 (1.2)















Reference line (AUC = 0.50)
Minimum joint space narrowing
(AUC = 0.73)
Source of the curve
Mean joint space narrowing
(AUC = 0.55)
Figure 1 Area under the receiver operating characteristic (ROC) curves
evaluating the predictive value of mean and minimum joint space
narrowing over three years for future knee surgery within five more
years.
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incidence of lower limb osteoarthritis surgery at least hazar-
dous, and at any rate impractical.
There is now a consensus within scientific organisations
and regulatory authorities for using radiographic changes—
that is, JSN over a period of two to three years—as a
surrogate for a hard clinical end point.2 3 6 However, as of
today no long term prospective clinical study has ever
unequivocally confirmed the surrogacy of JSN at the knee
for lower limb surgery. To be fully validated, a surrogate end
point should show a natural course closely related to that of
the relevant end point (thus a decrease in JSW would be
linked to an increase in the incidence of joint surgery). The
magnitude of the change in the surrogate responsible for a
subsequent increase or decrease in the end point should be
clearly defined (for example, a 0.5 mm decrease in JSW
would be linked to a twofold increase in the risk of joint
surgery). Eventually, this numerical relation should also be
validated following an external intervention, such as a
reduction in JSN by 50% resulting in a 25% decrease in the
incidence of joint surgery. In the present study, we show for
the first time from a long term prospective study that the
assessment of minimum JSN fulfils the two first require-
ments of the validation of this particular surrogate end point.
Previous studies have suggested that a 0.5 mm threshold of
JSN at the hip would be an appropriate cut off value, mainly
because this value corresponded to the smallest difference
between two measurements of JSW that exceeded the
measurement error.15 16 A decrease of 0.2 mm and 0.4 mm
in hip JSW after one or two years has also been significantly
associated with an increased risk of further hip arthroplasty
after five years, with corresponding ranges of sensitivity and
specificity of 68–75% and 67–78%, respectively.17 The figures
reported in the present study for a minimum JSN of the knee
between 0.5 and 0.8 mm after three years (overall efficiency
of between 73% and 75% for predicting the occurrence of
knee surgery five years later) compare favourably with these
results. On an individual basis, the negative predictive values
of our suggested thresholds (that is, the probability of surgery
in a patient with JSN below the cut off value) are high (92–
94%), but the positive predictive values (the probability of
surgery in a patient with JSN above the cut off value)
remains marginal (25–30%). When we look only at total knee
replacement, the negative and positive predictive values of
our suggested thresholds are 94–95% and 13–18%, respec-
tively. Thus our results re-emphasise the fact that clinical
considerations may be more important that radiological
features in the discussion process to undergo surgery.
We also, for the first time, provide a head to head
comparison of the respective value of mean and minimum
JSN assessment as predictor for the risk of future knee
surgery. While cut off values of minimum JSN between 0.5
and 0.8 mm after three years are all linked to a four- to
fivefold increase in the risk of future knee surgery (p=0.003
to 0.004), none of the selected thresholds of mean JSN (0.2 to
0.8 mm) was significantly related to the clinical outcome (p
values between 0.09 and 0.49). We have no definite
explanation for such a finding. It has previously been
reported that although the minimum joint space width could
be more sensitive for identifying changes in cartilage than the
mean joint space width, the latter is less sensitive to the
influence of variations in radiographic procedures and
patient positioning. Recently, the rate of tibial cartilage loss
over two years—assessed by magnetic resonance imaging—
has been found to be an independent predictor of knee
replacement at four years.18 We suggest that minimum joint
space width changes are significantly correlated with tibial
cartilage volume changes. However, more studies are needed
to confirm these particular findings.
Table 2 Relative risk* of various cut off points of joint space narrowing after three years
for the prediction of knee surgery within five subsequent years
3 Year JSN
RR for patients with JSN above the specified threshold after 3 y, compared with lower
rates of JSN
Mean JSN p Value Minimum JSN p Value
Above 0.2 mm 1.44 (0.49 to 4.16) 0.49 3.01 (1.09 to 8.26) 0.03
Above 0.3 mm 1.98 (0.68 to 5.78) 0.20 3.43 (1.24 to 9.53) 0.017
Above 0.4 mm 1.82 (0.58 to 5.68) 0.30 3.88 (1.39 to 10.86) 0.009
Above 0.5 mm 2.26 (0.71 to 7.21) 0.16 4.61 (1.65 to 12.84) 0.003
Above 0.6 mm 2.64 (0.83 to 8.39) 0.09 5.16 (1.76 to 15.12) 0.003
Above 0.7 mm 2.34 (0.68 to 8.06) 0.17 5.15 (1.70 to 15.60) 0.004
Above 0.8 mm 2.88 (0.83 to 9.97) 0.09 4.83 (1.64 to 14.20) 0.004
Values are relative risks and 95% confidence intervals.
*Adjusted for age, body mass index, total baseline WOMAC score, and baseline joint space width.
JSN, joint space narrowing; RR, relative risk; WOMAC, Western Ontario and McMaster Universities osteoarthritis
index; y, years.
Table 3 Sensitivity, specificity, positive predictive value, negative predictive value, and overall efficiency of various cut off
points of joint space narrowing after three years for predicting knee surgery within five years
3 Year JSN





















Above 0.2 mm 47 63 57 60 13 19 89 92 57 62
Above 0.3 mm 47 63 64 64 15 20 90 92 63 66
Above 0.4 mm 40 63 67 67 14 22 89 93 65 69
Above 0.5 mm 40 63 72 73 16 25 90 93 69 73
Above 0.6 mm 40 63 74 76 18 28 90 93 71 77
Above 0.7 mm 33 63 76 79 16 30 89 94 72 79
Above 0.8 mm 33 50 80 80 19 27 90 92 75 78
JSN, joint space narrowing; NPV, negative predictive value; PPV, positive predictive value.
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We also show in the present study that, even though other
radiographic views of the knee joint might be more
appropriate today than the fully extended approach, this
particular view remains of significant interest as the radio-
graphic changes observed with this technique after three
years are significantly predictive of future knee surgery.
Conclusions
We conclude that, on the basis of a cohort of patients initially
followed over three years in a randomised controlled trial for
which standardised and digitally analysed x rays of the signal
joint were available, minimum JSN is highly predictive of the
risk of undergoing osteoarthritis related joint surgery during
the ensuing five years. These data form a piece of evidence in
the validation process of minimum JSN assessment as a
surrogate for a hard clinical end point in knee osteoarthritis.
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